Microparticle-associated tissue factor activity in plasma is unaffected by cytolytic chemotherapy treatment in metastatic testicular cancer patients

Thrombosis Research

Volumn 131, Issue 2, 2013, Pages 187-189

  Van Den Hengel, Lisa G ^a   Van Steijn Van Tol, A Q M Jeanne ^a   Bertina, Rogier M ^a   Versteeg, Henri H ^a   Osanto, Susanne ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7; CISPLATIN; ETOPOSIDE; THROMBOPLASTIN; VON WILLEBRAND FACTOR;

ANGINA PECTORIS; APOPTOSIS; BLOOD CLOTTING; BLOOD SAMPLING; CANCER CELL; CANCER CHEMOTHERAPY; CELL DEATH; CYTOLYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART INFARCTION; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; ORCHIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TESTIS CARCINOMA; THROMBOCYTE ACTIVATION; TREATMENT RESPONSE; VASCULAR ENDOTHELIUM; VENOUS THROMBOEMBOLISM;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CELL-DERIVED MICROPARTICLES; CISPLATIN; ETOPOSIDE; HUMANS; MALE; NEOPLASM METASTASIS; TESTICULAR NEOPLASMS; THROMBOPLASTIN;

EID: 84872283537     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.11.026     Document Type: Letter

References (8)

1. J.A. Heit, M.D. Silverstein, D.N. Mohr, T.M. Petterson, W.M. O'Fallon, and L.J. Melton III Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study Arch Intern Med 160 2000 809 815
2. S. Barni, R. Labianca, G. Agnelli, E. Bonizzoni, M. Verso, and M. Mandala Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study J Transl Med 9 2011 179
3. N.I. Weijl, M.F. Rutten, A.H. Zwinderman, H.J. Keizer, M.A. Nooy, and F.R. Rosendaal Thromboembolic events during chemotherapy for germ cell cancer: a cohort study and review of the literature J Clin Oncol 18 2000 2169 2178
4. D. Lechner, and A. Weltermann Chemotherapy-induced thrombosis: a role for microparticles and tissue factor? Semin Thromb Hemost 34 2008 199 203
5. A.A. Khorana, C.W. Francis, K.E. Menzies, J.G. Wang, O. Hyrien, and J. Hathcock Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer J Thromb Haemost 6 2008 1983 1985
6. M.E. Tesselaar, F.P. Romijn, I.K. Van Der Linden, R.M. Bertina, and S. Osanto Microparticle-associated tissue factor activity in cancer patients with and without thrombosis J Thromb Haemost 7 2009 1421 1423
7. K.P. Dieckmann, W.J. Struss, and U. Budde Evidence for acute vascular toxicity of cisplatin-based chemotherapy in patients with germ cell tumour Anticancer Res 31 2011 4501 4505
8. P. Tjernberg, H.L. Vos, G. Castaman, R.M. Bertina, and J.C. Eikenboom Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues J Thromb Haemost 2 2004 257 265